A preview of the PDF is not available
Limitations of the BCG vaccine and new prophylaxis strategies against human tuberculosis
Abstract and Figures
BCG (Bacille Calmette Guérin), an attenuated vaccine derived from Mycobacterium bovis, is the current vaccine against tuberculosis. Notwithstanding its protection of children, BCG has failed to protect adults against active pulmonary tuberculosis, especially in countries where the disease is endemic. Any new tuberculosis vaccine should protect several categories of people, including children, adults, the elderly and immunodeppressed patients. An important feature is immunization safety for all of these classes. The aim of this review is to describe new vaccination strategies, such as subunit vaccines, DNA vaccines, vaccines with live microorganisms and vectors, and to discuss the application of these new strategies for the control and eradication of tuberculosis.
Figures - uploaded by Ana Paula Junqueira-Kipnis
All figure content in this area was uploaded by Ana Paula Junqueira-Kipnis
Content may be subject to copyright.